Necrosis in DU145 prostate cancer spheroids induces COX-2/mPGES-1-derived PGE2 to promote tumor growth and to inhibit T cell activation (Q39174587)

9 September 2017

Necrosis in DU145 prostate cancer spheroids induces COX-2/mPGES-1-derived PGE2 to promote tumor growth and to inhibit T cell activation (English)

1 reference

9 September 2017

1 reference

4

Olof Rådmark

1 reference

9 September 2017

6

Bernhard Brüne

1 reference

9 September 2017

Weixiao Sha

1

1 reference

9 September 2017

Catherine Olesch

series ordinal

2

1 reference

9 September 2017

Hiromi Hanaka

series ordinal

3

1 reference

9 September 2017

Andreas Weigert

series ordinal

5

1 reference

9 September 2017

language of work or name

English

0 references

publication date

22 April 2013

1 reference

International Journal of Cancer

9 September 2017

1 reference

9 September 2017

133

1 reference

9 September 2017

7

1 reference

9 September 2017

1578-1588

1 reference

Immune surveillance against a solid tumor fails because of immunological ignorance

9 September 2017

1 reference

Yin-yang activities and vicious cycles in the tumor microenvironment

21 January 2018

1 reference

Hypoxia, HIF1 and glucose metabolism in the solid tumour

21 January 2018

1 reference

21 January 2018

1 reference

Tumor promotion via injury- and death-induced inflammation

21 January 2018

1 reference

Prostaglandins and inflammation

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Eicosanoids and cancer

1 reference

Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung

21 January 2018

1 reference

Prostaglandins, NSAIDs, and Gastric Mucosal Protection: Why Doesn't the Stomach Digest Itself?

21 January 2018

1 reference

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

21 January 2018

1 reference

Genetic deletion of mPGES-1 suppresses intestinal tumorigenesis

21 January 2018

1 reference

Genetic deletion of mPGES-1 accelerates intestinal tumorigenesis in APC(Min/+) mice

21 January 2018

1 reference

Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells

21 January 2018

1 reference

Apoptotic tumor cells induce IL-27 release from human DCs to activate Treg cells that express CD69 and attenuate cytotoxicity

21 January 2018

1 reference

Cleavage of sphingosine kinase 2 by caspase-1 provokes its release from apoptotic cells.

21 January 2018

1 reference

Dimethylcelecoxib inhibits mPGES-1 promoter activity by influencing EGR1 and NF-κB.

21 January 2018

1 reference

WNT and cyclooxygenase-2 cross-talk accelerates adenoma growth

21 January 2018

1 reference

Adaptive immunity maintains occult cancer in an equilibrium state

21 January 2018

1 reference

Prostaglandin E2 inhibits IFN-alpha secretion and Th1 costimulation by human plasmacytoid dendritic cells via E-prostanoid 2 and E-prostanoid 4 receptor engagement

21 January 2018

1 reference

A fresh look at tumor immunosurveillance and immunotherapy.

21 January 2018

1 reference

M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells

21 January 2018

1 reference

Signal pathways JNK and NF-kappaB, identified by global gene expression profiling, are involved in regulation of TNFalpha-induced mPGES-1 and COX-2 expression in gingival fibroblasts

21 January 2018

1 reference

Transforming growth factor beta regulates cyclooxygenase-2 in glomerular mesangial cells

21 January 2018

1 reference

Colon tumour cells increase PGE(2) by regulating COX-2 and 15-PGDH to promote survival during the microenvironmental stress of glucose deprivation

21 January 2018

1 reference

Apoptotic cells activate the "phoenix rising" pathway to promote wound healing and tissue regeneration

21 January 2018

1 reference

Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy

21 January 2018

1 reference

Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2.

21 January 2018

1 reference

Loss of cancer drug activity in colon cancer HCT-116 cells during spheroid formation in a new 3-D spheroid cell culture system.

21 January 2018

1 reference

Apoptotic cell-derived sphingosine-1-phosphate promotes HuR-dependent cyclooxygenase-2 mRNA stabilization and protein expression

21 January 2018

1 reference

Combinational therapy: new hope for pancreatic cancer?

21 January 2018

1 reference

Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors

21 January 2018

1 reference

Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues

21 January 2018

1 reference

Killing a cancer: what are the alternatives?

21 January 2018

1 reference

Regulation of immune responses by prostaglandin E2

21 January 2018

1 reference

Prostaglandin E2, an immunoactivator.

21 January 2018

1 reference

Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28181

1 reference

9 September 2017

1 reference